van der Heijden, M. S. Et Al. 2023. Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma. NEW ENGLAND JOURNAL OF MEDICINE , vol.389 , 1778-1789.

van der Heijden, M. S., Sonpavde, G., Powles, T., Necchi, A., Burotto, M., Schenker, M., ... Sade, J. P.(2023). Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma. NEW ENGLAND JOURNAL OF MEDICINE , vol.389, 1778-1789.

van der Heijden, M. Et Al. "Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma," NEW ENGLAND JOURNAL OF MEDICINE , vol.389, 1778-1789, 2023

van der Heijden, M. S. Et Al. "Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma." NEW ENGLAND JOURNAL OF MEDICINE , vol.389, pp.1778-1789, 2023

van der Heijden, M. S. Et Al. (2023) . "Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma." NEW ENGLAND JOURNAL OF MEDICINE , vol.389, pp.1778-1789.

@article{article, author={M. S. van der Heijden Et Al. }, title={Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2023, pages={1778-1789} }